Cabaletta Bio Inc (NASDAQ: CABA) on Monday, soared 9.47% from the previous trading day, before settling in for the closing price of $4.54. Within the past 52 weeks, CABA’s price has moved between $3.47 and $26.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -36.37%. With a float of $42.14 million, this company’s outstanding shares have now reached $47.82 million.
The extent of productivity of a business whose workforce counts for 103 workers is very important to gauge. In terms of profitability, gross margin is 62.34%, operating margin of -2496.86%, and the pretax margin is -2243.97%.
Cabaletta Bio Inc (CABA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cabaletta Bio Inc is 13.73%, while institutional ownership is 95.43%. The most recent insider transaction that took place on Jan 19 ’24, was worth 215,439. In this transaction an insider of this company sold 11,000 shares at a rate of $19.59, taking the stock ownership to the 20,000 shares. Before that another transaction happened on Dec 19 ’23, when Company’s See Remarks sold 11,000 for $21.89, making the entire transaction worth $240,789. This insider now owns 20,000 shares in total.
Cabaletta Bio Inc (CABA) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.37 earnings per share (EPS) for the period topping the consensus outlook (set at -0.4) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.37% per share during the next fiscal year.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
Cabaletta Bio Inc (CABA) is currently performing well based on its current performance indicators. A quick ratio of 11.52 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -2.41 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
The latest stats from [Cabaletta Bio Inc, CABA] show that its last 5-days average volume of 0.96 million was inferior to 1.14 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 36.38%. Additionally, its Average True Range was 0.59.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 9.63%, which indicates a significant decrease from 39.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 185.79% in the past 14 days, which was higher than the 105.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.43, while its 200-day Moving Average is $15.28. Now, the first resistance to watch is $5.19. This is followed by the second major resistance level at $5.40. The third major resistance level sits at $5.75. If the price goes on to break the first support level at $4.63, it is likely to go to the next support level at $4.28. Assuming the price breaks the second support level, the third support level stands at $4.07.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
Market capitalization of the company is 242.78 million based on 48,277K outstanding shares. Right now, sales total 0 K and income totals -67,680 K. The company made 0 K in profit during its latest quarter, and -27,600 K in sales during its previous quarter.
